Investing

Longboard Pharmaceuticals Inc : LBPH

LBPH

Stock Data

$59.98

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Longboard Pharmaceuticals Inc is a biopharmaceutical company in the clinical stage, dedicated to creating innovative medicines for neurological disorders. Its flagship product, LP352, is undergoing clinical trials aimed at treating severe seizure conditions. Alongside LP352, Longboard is working on LP659 and LP143 for various neurological diseases, under a licensing agreement with Arena Pharmaceuticals. Originally named Arena Neuroscience, the company, established in 2020 and based in La Jolla, California, rebranded to Longboard Pharmaceuticals in October 2020.